ScholarIQanswers from OpenAlex & ORCID
Seth M. Pollack
ResearcherPublications, citations & collaboration network
Seth M. Pollack is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Seth M. Pollack have?
ScholarIQindexed works
Seth M. Pollack has 303 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Seth M. Pollack have?
ScholarIQcitation count
Seth M. Pollack has 5,180 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Seth M. Pollack?
ScholarIQh-index
Seth M. Pollack has an h-index of 35 in OpenAlex.
What is the i10-index of Seth M. Pollack?
ScholarIQi10-index
Seth M. Pollack has an i10-index of 72 in OpenAlex.
What is the ORCID of Seth M. Pollack?
ScholarIQorcid
The ORCID for Seth M. Pollack is on the source record.
What is the OpenAlex record for Seth M. Pollack?
ScholarIQopenalex
The OpenAlex for Seth M. Pollack is on the source record.
What are the most-cited papers on Seth M. Pollack?
ScholarIQmost cited works
Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Margaret von Mehren, John M. Kane, Mark Agulnik, Marilyn M. Bui, Janai R. Carr, Edwin Choy, Mary Connelly, Sarah Dry, Kristen N. Ganjoo, Ricardo González, Ashley M. Holder, Jade Homsi, Vicki L. Keedy, Ciara M. Kelly, Edward Kim, David A. Liebner, Martin D. McCarter, Sean V. McGarry, Nathan W. Mesko, Christian F. Meyer, Alberto S. Pappo, Amanda Parkes, Ivy A. Petersen, Seth M. Pollack, Matthew M. Poppe, Richard F. Riedel, Scott M. Schuetze, Jacob E. Shabason, Jason K. Sicklick, Matthew B. Spraker, Melissa N. Zimel, Lisa E. Hang, Hema Sundar, Mary Anne Bergman
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial
Sandra P. D’Angelo, Dejka M. Araujo, Albiruni R. Abdul Razak, Mark Agulnik, Steven Attia, Jean‐Yves Blay, Irene Carrasco García, John A. Charlson, Edwin Choy, George D. Demetri, Mihaela Druta, Édouard Forcade, Kristen N. Ganjoo, John Glod, Vicki L. Keedy, Axel Le Cesne, David A. Liebner, Víctor Moreno, Seth M. Pollack, Scott M. Schuetze, Gary K. Schwartz, Sandra J. Strauss, William D. Tap, Fiona Thistlethwaite, Claudia Maria Valverde Morales, Michael J. Wagner, Breelyn A. Wilky, Cheryl McAlpine, Laura Hudson, Jean‐Marc Navenot, Tianjiao Wang, Jane P. F. Bai, Stavros Rafail, Ruoxi Wang, Amy Sun, Lilliam Fernandes, Erin Van Winkle, Erica Elefant, Colin Lunt, Elliot Norry, Dennis Williams, Swethajit Biswas, Brian Andrew Van Tine
T‐cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death‐ligand 1 expression in patients with soft tissue sarcomas
Seth M. Pollack, Qianchuan He, Jennifer H. Yearley, Ryan Emerson, Marissa Vignali, Yuzheng Zhang, Mary W. Redman, Kelsey K. Baker, Sara J. Cooper, Bailey Donahue, Elizabeth T. Loggers, Lee D. Cranmer, Matthew B. Spraker, Yongwoo David Seo, Venu G. Pillarisetty, Robert W. Ricciotti, Benjamin Hoch, Terrill K. McClanahan, Erin Murphy, Wendy M. Blumenschein, Steven M. Townson, Sharon Benzeno, Stanley R. Riddell, Robin L. Jones
Mobilization of CD8+ T Cells via CXCR4 Blockade Facilitates PD-1 Checkpoint Therapy in Human Pancreatic Cancer
Yongwoo David Seo, Xiuyun Jiang, Kevin M. Sullivan, Florencia G. Jalikis, Kimberly S. Smythe, Arezou Abbasi, Marissa Vignali, James O. Park, Sara K. Daniel, Seth M. Pollack, Teresa S. Kim, Raymond S. Yeung, Ian Nicholas Crispe, Robert H. Pierce, Harlan Robins, Venu G. Pillarisetty
Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial
Shihong Zhang, Karan Kohli, Graeme Black, Yao Lu, Sydney M. Spadinger, Qianchuan He, Venu G. Pillarisetty, Lee D. Cranmer, Brian A. Van Tine, Cassian Yee, Robert H. Pierce, Stanley R. Riddell, Robin L. Jones, Seth M. Pollack